Another study demonstrated the novel beneficial aspect of azelnidipine, whereby azelnidipine could play a protective role against atherosclerosis by suppressing monocyte chemoattractant protein-1 overexpression in endothelial cells [36]. The gene discussed is CCL2; the disease is atherosclerosis.